Marcella Mottolese Selected Research

Male Breast Neoplasms (Male Breast Cancer)

10/2018	Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.
5/2017	A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer.
1/2017	Characterisation of male breast cancer: a descriptive biomarker study from a large patient series.
10/2016	HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.
11/2015	Androgen receptor and antiandrogen therapy in male breast cancer.
5/2015	Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis.
3/2015	Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study.
11/2014	Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
6/2012	A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcella Mottolese Research Topics

Disease

57	Neoplasms (Cancer) 01/2021 - 05/2001
56	Breast Neoplasms (Breast Cancer) 07/2019 - 05/2001
14	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2010
12	Carcinoma (Carcinomatosis) 01/2018 - 09/2002
9	Male Breast Neoplasms (Male Breast Cancer) 10/2018 - 06/2012
8	Disease Progression 12/2020 - 10/2005
8	Neoplasm Metastasis (Metastasis) 07/2019 - 12/2005
6	Triple Negative Breast Neoplasms 01/2018 - 12/2015
6	Melanoma (Melanoma, Malignant) 01/2014 - 05/2002
5	Carcinogenesis 01/2019 - 03/2006
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018 - 09/2010
3	Prostatic Neoplasms (Prostate Cancer) 09/2009 - 02/2006
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 12/2017 - 09/2004
2	Rare Diseases (Rare Disease) 08/2017 - 11/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2016 - 01/2016
2	Residual Neoplasm 12/2015 - 06/2002
2	Genomic Instability 04/2015 - 08/2014
2	Adenocarcinoma 04/2012 - 08/2008
2	Papillomavirus Infections 10/2010 - 03/2006
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018
1	Pathologic Complete Response 01/2018
1	Glioma (Gliomas) 01/2017

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2004
14	Proteins (Proteins, Gene)FDA Link 06/2020 - 05/2004
13	Trastuzumab (Herceptin)FDA Link 01/2018 - 11/2004
11	Hormones (Hormone)IBA 12/2020 - 01/2007
10	ErbB Receptors (EGF Receptor)IBA 09/2013 - 05/2001
9	Biological ProductsIBA 02/2015 - 05/2001
8	Phenobarbital (Luminal)FDA Link 07/2019 - 02/2006
6	Estrogen ReceptorsIBA 10/2017 - 08/2014
6	AnthracyclinesIBA 11/2016 - 02/2004
5	Phosphotransferases (Kinase)IBA 01/2022 - 04/2015
5	LigandsIBA 10/2018 - 09/2004
5	MicroRNAs (MicroRNA)IBA 01/2018 - 06/2010
5	Progesterone Receptors (Progesterone Receptor)IBA 10/2017 - 03/2006
5	Messenger RNA (mRNA)IBA 01/2017 - 03/2005
5	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 11/2007
4	Pharmaceutical PreparationsIBA 02/2017 - 02/2008
4	human ERBB2 proteinIBA 08/2015 - 03/2006
4	Protein Isoforms (Isoforms)IBA 11/2014 - 08/2008
4	Epidermal Growth Factor (EGF)IBA 12/2010 - 03/2006
4	Monoclonal AntibodiesIBA 09/2010 - 05/2001
3	Oncogene Proteins (Oncogene Protein)IBA 06/2016 - 05/2001
3	Androgen Antagonists (Antiandrogens)IBA 11/2015 - 11/2014
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014 - 07/2003
3	Peptides (Polypeptides)IBA 01/2014 - 05/2001
3	HLA-A Antigens (HLA-A)IBA 01/2014 - 01/2007
3	ParaffinIBA 10/2011 - 05/2001
3	Indicators and Reagents (Reagents)IBA 12/2010 - 05/2001
3	AntibodiesIBA 09/2006 - 05/2001
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 07/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2020 - 01/2019
2	Metalloproteases (Metalloproteinases)IBA 10/2018 - 12/2005
2	SilverIBA 10/2017 - 04/2011
2	Nucleic AcidsIBA 01/2017 - 01/2013
2	Keratin-19 (Keratin 19)IBA 01/2017 - 01/2013
2	Taxoids (Taxanes)IBA 11/2016 - 09/2008
2	Androgen Receptors (Androgen Receptor)IBA 11/2015 - 11/2014
2	Glucose (Dextrose)FDA LinkGeneric 08/2015 - 11/2014
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 05/2015 - 11/2014
2	Aromatase InhibitorsIBA 05/2015 - 10/2005
2	Cyproterone AcetateIBA 05/2015 - 11/2014
2	taxaneIBA 01/2015 - 10/2008
2	Vitamin D FDA LinkGeneric 01/2015 - 01/2013
2	Estrogens (Estrogen)FDA Link 10/2014 - 03/2006
2	HLA-B Antigens (HLA-B)IBA 01/2014 - 01/2007
2	HLA-C Antigens (HLA-C)IBA 01/2014 - 01/2007
2	Cyclin D1IBA 12/2013 - 02/2007
2	Capecitabine (Xeloda)FDA Link 04/2013 - 09/2008
2	Tyrosine Kinase InhibitorsIBA 04/2013 - 09/2010
2	Bevacizumab (Avastin)FDA Link 01/2013 - 09/2012
2	Formaldehyde (Formol)FDA Link 10/2011 - 01/2007
2	Integrin alpha6beta4IBA 07/2009 - 02/2008
2	Estrogen Receptor betaIBA 05/2009 - 01/2008
2	thiamine triphosphorate (TTP)IBA 09/2008 - 10/2005
2	EnzymesIBA 09/2008 - 01/2007
2	Tamoxifen FDA LinkGeneric 02/2008 - 10/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2007 - 07/2006
2	Antisense OligonucleotidesIBA 03/2005 - 11/2004
2	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2002 - 05/2002
1	IntegrinsIBA 10/2018
1	teleocalcinIBA 10/2018
1	Fibronectins (Fibronectin)IBA 10/2018
1	Conditioned Culture MediaIBA 01/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	prexasertibIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2017
1	Everolimus FDA Link 05/2017
1	Eukaryotic Initiation Factor-4EIBA 05/2017
1	A-Form DNA (A-DNA)IBA 02/2017
1	Frizzled ReceptorsIBA 02/2017
1	Telomeric Repeat Binding Protein 2IBA 01/2017

Therapy/Procedure

24	Therapeutics 12/2020 - 02/2004
21	Drug Therapy (Chemotherapy) 01/2018 - 06/2002
7	Neoadjuvant Therapy 01/2017 - 06/2002
3	Adjuvant Chemotherapy 01/2021 - 03/2013
2	Ligation 10/2017 - 11/2014
2	Prostatectomy (Retropubic Prostatectomy) 09/2009 - 02/2006